Skip to main content
VCbacked
Log inGet Started

Elixirgen Therapeutics

Baltimore, United States

Elixirgen Therapeutics is a biotechnology company that specializes in the development of therapies for genetic diseases and vaccines.

$7.0M raised
Nov 2023
Venture - Series Unknown
BiotechnologyHealth CareTherapeutics

Top Investors

UTEC - The University of Tokyo Edge Capital Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Elixirgen Therapeutics

How much funding has Elixirgen Therapeutics raised?
Elixirgen Therapeutics has raised $7.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.
Who are Elixirgen Therapeutics's investors?
Elixirgen Therapeutics's investors include UTEC - The University of Tokyo Edge Capital Partners.
Where is Elixirgen Therapeutics headquartered?
Elixirgen Therapeutics is headquartered in Baltimore, United States.
What does Elixirgen Therapeutics do?
Elixirgen Therapeutics is a biotechnology company that specializes in the development of therapies for genetic diseases and vaccines.
What stage is Elixirgen Therapeutics at?
Elixirgen Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Elixirgen Therapeutics — Funding & Investors." VCBacked, November 9, 2023, https://www.vcbacked.co/company/elixirgen-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). Elixirgen Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/elixirgen-therapeutics
Wikipedia (cite web)
{{cite web |title=Elixirgen Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/elixirgen-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong